 |
 |
 |
 |
|
Animated image of a cell during apoptosis. During apoptosis, the plasma membrane gives rise to blebs from the cell surface |
Hematoxylin-eosin stained image of an apoptotic cell in the liver (arrow) |
Ultrastructural appearance of apoptotic lymphoid cells (arrowheads). The nuclei have a condensed chromatin.
|
Role of NF-kappa B in TNF-alpha induced apoptosis The term apoptosis is derived from the Greek word that signifies the dropping of leaves from the trees. This term is applied to a group of characteristic structural and molecular events that separate this type of cell deletion from necrosis (Table I). In contrast to necrosis that involves a group of cells simultaneously, apoptosis may occur in a single cell surrounded by a group of viable cells. There is a distinct and precisely localized control over the fate of specific cells in a mixed cell population that undergo apoptosis. Apoptosis is a selective process for deletion of cells in various biological systems. This event similar to proliferation is tightly regulated (table II) with both processes playing essential roles in the homeostasis of renewable tissues.
A diverse group of signals induce apoptosis (Table III). Based on sequence homology, a large family of molecules collectively called the nerve growth factor/TNF receptor family of apoptosis inducing signaling proteins has been identified (Table IV). In addition, the extracellular domains of the TNFr family bears significant homology to the open reading frames (ORFs) of several viruses. Over the past two years, ligands for most of the known receptors of the nerve growth factor/TNF receptor family have been identified. These ligands are all type II transmembrane proteins and show homology to TNF and lymphotoxin (LT) and therefore belong to a TNF family of molecules.
TNF-alpha is one of the prime signals that induces apoptosis in a host of cells. TNF-alpha also activates the transcription factor NF-kappa B. It has not been clear whether the TNF-alpha induced apoptosis and activation of NF-kappa B are linked. In the November 1, 1996 issue of Science, three groups report that these effects of TNF-alpha are linked. NF-kappa B plays a protective role in the apoptosis induced by TNF-alpha (Wang et al. 1996, Antwerp et al, 1996, Beg and Baltimore, 1996). In addition, the activation of this transcription factor, plays a similar role in the apoptosis induced by ionizing radition and the chemotherapeutic agent, daunorubricin (Wang et al, 1996).
The most common forms of the NF-kappa B is a 50 kd heterodimer protein (p50) and a 65 kd protein which is also called RelA or p65. These investigators showed that the protective effect of the NF-kappa B is mediated by NF-kappa B subunits. Treatment of the RelA deficient mouse fibroblasts (Rel A -/-) and macrophages with TNF-alpha resulted in apoptosis of a significant number of cells whereas the RelA (+/+) cells were spared from this effect of TNF-alpha. Reintroduction of the RelA into the Rel A -/- promoted survival of the cells after treatment with TNF-alpha (Beg and Baltimore, 1996). Expression of p65 and p55 also confered protection against apoptosis induced by TNF-alpha (Wang et al, 1996). The apoptosis inducing effect of TNF-alpha was also enhanced by a proteasome inhibitor, MG132 (Z-Leu-Leu-Leu-H), that inhibits the NF-kappa B (Wang et al, 1996) and by dominant-negative I B M (Antwerp et al, 1996). On the other hand, the apoptosis induced by a combination of TNF-alpha and cyclohexamide was inhbited by IL-1 that is a strong activator of NF-kappa B (Wang et al, 1996). Taken together, the findings show that NF-kappa B protects against the apoptosis induced by TNF-alpha. This insight would be useful for devising strategies in the treatment of cancer and inflammatory responses that involve TNF-alpha.
REFERENCES:
Wang C-Y, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF- B. and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science, 274, 784-787">Science, 274, 784-787
Antwerp DJV, Martin SJ, Kafri T, Green DR, Verma IM: Suprresion of TNF- -induced apoptosis by NF- B: Science 274, 787-789
Beg AA, Baltimore D: An essential role of NF- B in preventing TNF- induced cell death. Science, 274, 782-784, 1996
Table I Features that allow distinction of apoptosis from necrosis |
| FEATURE |
APOPTOSIS |
NECROSIS |
|
Stimuli |
Physical/Pathological |
Pathological |
| Occurrence
| Single cells
| Group of cells |
| Adhesion between cells and to basement membrane
| Lost (early)
| Lost (late) |
| Cytoplasmic swelling
| Late stage
| Very early |
| Damage to organelles
| Late
| Early |
| Release of lysosomal enzymes
| Absent
| Present |
| Nucleus
| Convolution of nuclear outline and breakdown(karyorrhexis)
| Disappearance of nuclei (karyolysis) |
| Nuclear chromatin
| Compaction in uniformly dense masses
| Clumping, not sharply defined |
| DNA breakdown
| Internucleosomal (formation of DNA ladder)
| Random (smearing) |
| utcome
| Formation of apoptotic bodies
| Swelling and disintegration |
| Phagocytosis by other cells
| Present
| Absent |
| Exudative inflammation
| Present
| Absent |
| Scar formation
| Absent
| Present |
Table II Phases of programmed cell death and its features |
D1(Reversible)
Genetic reprogramming
- Change in protein profile
- Increased stress proteins
- Decreased polyamines
- Chromatin changes
- Increased Ca2+
| F (Irreversible)
- Activation of endonuclease
- Fragmentation of genomic DNA
| D2 (Irreversible)
- Morphologic changes
-Protein crosslinking by transglutaminase
-Formation of apoptotic bodies
-Phagocytosis of apoptotic bodies
|
Table III Apoptosis inducing signals
|
CHEMICALS
Chemotherapeutic agents
Glucocorticoids
Free-radicals
Glutamate
Calcium
Azide
Hydrogen peroxide
|
PPHYSICAL INSULTS
Neutrons
X-rays
ß-rays
Gamma-rays
UV-radiation
Heat shock
| VIRUSES
HIV-1
Sindbis
Baculo
| CELLS
Cytolytic T cells
| CYTOKINES
TNF-
TGF-ß
| WITHDRAWAL FROM TROPHIC FACTORS
Glucose
Growth factors
(Interleukin-2, Interleukin-3, Interleukin-10, Interleukin-13, Granulocyte-macrophage colony
stimulating factor, Granulocyte stimulating factor, Fibroblast growth factor, Transforming growth factor ß1,
Neurotrophic factor)
Hormones (Estrogen, Androgen, Progesterone, ACTH)
| OTHERS
Glucocorticoids
p53
c-myc
Ced-2,3,4
Ced 9 gene mutants in C-Elegans
Fas/Apo-1 (CD95)
IL-1ß converting enzyme
|
Table IV
TNF family of molecules
| |
NAME
| MW (kD)
|
TNF- | 26(17)
|
LT- | 25
|
|
LTß | 33
|
|
CD40L | 33
|
|
CD30L | 40
/tr> |
|
CD27L | 50
/tr> |
|
FasL | 38-42*
/tr> |
|
4-1BBL | 50
/tr> |
|
OX40L | 28-32
|
MW: Molecular weight, kD: Kilodalton, L: ligand, ND: not defined,
TNF : Tumor necrosis factor, LT: Lymphotoxin *: rat Fas ligand.
17 kD shown in the parentheses is the mature secreted form of TNF-
|
RESOURCES:
APOPTOSIS Online
NIH Apoptosis Interest Group
Most cited apoptosis papers, 1981-94
Guide to Cell Proliferation and Apoptosis Methods
Apoptosis companies
Apoptosis markers
Apoptosis detection kits
Apoptosis Detection Kit - R&D Systems
Apoptosis Detection Kit - Typical Fluorescence Dot Plots
DermPathTutor©-Apoptosis
Apoptosis Quantitation Using HO 33342
Identification of apoptotic cells by flow cytometry
Cells Alive
|
 |